Document is current
Any future updates will be listed below
-
Authors
Smith, Hadley Stevens https://orcid.org/0000-0003-1247-6535
Vu, Martin
Dangouloff, Tamara https://orcid.org/0000-0002-5435-4774
Schubert, Camille https://orcid.org/0000-0003-0828-1612
Level, Camille
Lamsal, Ramesh
Christensen, Kurt D. https://orcid.org/0000-0003-4068-776X
Stark, Zornitza https://orcid.org/0000-0001-8640-1371
Goranitis, Ilias https://orcid.org/0000-0001-7946-8324
Aujla, Matthew
Westover, Thomas
Ponte, Amy https://orcid.org/0000-0003-3023-357X
Shah, Nidhi https://orcid.org/0000-0003-0851-8376
Servais, Laurent https://orcid.org/0000-0001-9270-4061
Bailey, Miranda
Lavelle, Tara A.
Grosse, Scott D. https://orcid.org/0000-0003-1078-6855
Norris, Sarah https://orcid.org/0000-0002-4733-6906
Buchanan, James https://orcid.org/0000-0003-2528-0638
- License Information
-
More Information
Article History
Received: 8 December 2025
Revised: 21 April 2026
Accepted: 5 May 2026
First Online: 4 June 2026
Competing interests
: HSS reports consulting income from Illumina, Inc. unrelated to this work. MV received a PhD (independent) scholarship from Illumina under the University of Melbourne/Illumina partnership. JB reports travel funding from Illumina, Inc. and consulting income from Genomics England. AP is an employee of Sanofi and may hold stock/stock options in the company. MB is an employee of Rocket Pharmaceuticals and may hold stock/stock options in the company. TD has given lectures sponsored by Biogen and Roche. LS gave consultancy to Illumina, Sanofi, LaCaer and is non-remunerated member of the board of directors of Thameus. TW is a past consultant to Illumina, Labcorp, Sequenom, Natera, myriad, Billion to one, Coalition to advance prenatal screening.
: This study was approved by the Harvard Pilgrim Health Care Institutional Review Board. Participants provided informed consent for the survey research study using standard online survey procedures.
